Single-enantiomer drugs: Elegant science, disappointing effects

Clinical Pharmacokinetics

Volumn 43, Issue 5, 2004, Pages 287-290

  Mansfield, Peter ^a   Henry, David ^b,c   Tonkin, Anne ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM; ESOMEPRAZOLE; LEVALBUTEROL; OMEPRAZOLE; SALBUTAMOL;

DRUG COST; DRUG EFFICACY; DRUG SAFETY; ENANTIOMER; EVIDENCE BASED MEDICINE; HUMAN; PATENT; PERCEPTION; PREDICTION; PRIORITY JOURNAL; RACEMIC MIXTURE; REVIEW; SIDE EFFECT;

ALBUTEROL; ANTI-ASTHMATIC AGENTS; ANTI-ULCER AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; COST-BENEFIT ANALYSIS; GASTROESOPHAGEAL REFLUX; HUMANS; OMEPRAZOLE; STEREOISOMERISM;

EID: 2042470125     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200443050-00002     Document Type: Review

References (23)

1. Burke WJ, Kratochvil CJ. Stereoisomers in psychiatry: the case of escitalopram. Prim Care Companion J Clin Psychiatry 2002; 4: 20-4
2. Tucker GT. Chiral switches. Lancet 2000; 355: 1085-7
3. Vakily M, Mehvar R, Brocks D, et al. Stereoselective pharmacokinetics and pharmacodynamics of anti-asthma agents. Ann Pharmacother 2002; 36: 693-701
4. Mehvar R, Brocks DR, Vakily M. Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of anti-arrhythmic drugs. Clin Pharmacokinet 2002; 41: 533-58
5. Baker GB, Prior TL. Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs. Ann Med 2002; 34: 537-43
6. Thomas JM, Schug SA. Recent advances in the pharmacokinetics of local anaesthetics: long-acting amide enantiomers and continuous infusions. Clin Pharmacokinet 1999; 36: 67-83
7. Stoschitzky K, Zernig G, Lindner W. Racemic beta-blockers: fixed combinations of different drugs. J Clin Basic Cardiol 1998; 1: 14-8
8. Greenspan FS, Dong BJ. Thyroid and antithyroid drugs. In: Katzung BG, editor. Basic and clinical pharmacology. 8th ed. New York: Lange Medical Books, 2001
9. Farwell AP, Braverman LE. Thyroid and antithyroid drugs. In: Hardman JG, Limbird LE, Goodman Gilman LS, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill, 2001: 1565
10. Agranat I, Caner H, Caldwell J. Putting chirality to work: the strategy of chiral switches. Nat Rev Drug Discov 2002 Oct; 1 (10): 753-68
11. DeVane CL, Boulton DW. Great expectations in stereochemistry: focus on antidepressants. CNS Spectrums 2002; 7 Suppl. 1: 28-33
12. Anon. Do single stereoisomer drugs provide value? Therapeutics Letter 2002 [online]. Available from URL: http://www.ti.ubc.ca/PDF/45.pdf [Accessed 2004 Feb 11]
13. Svensson S, Mansfield PR. Escitalopram: superior to citalopram or chiral chimera? Psychother Psychosom 2004 Jan-Feb; 73(1): 10-6
14. Waldeck B. Enantiomers of bronchodilating beta2-adrenoceptor agonists: is there cause for concern? J Allergy Clin Immunol 1999; 103: 742-8
15. Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectrums 2002; 7 Suppl. 1: 40-4
16. Kahrilas PJ, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial: The Esomeprazole Study Investigators. Aliment Pharmacol Ther 2000 Oct; 14 (10): 1249-58
17. Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998; 102: 943-52
18. Richter JE, Kahrilas PJ, Johanson J, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 2001 Mar; 96 (3): 656-65
19. Healthy Skepticism. AdWatch on Nexium [online]. Available from URL: http://www.healthyskepticism.org/adwatch/au/2003/nexium.asp [Accessed 2004 Feb 11]
20. Boulton DW, Fawcett JP. Beta2-agonist eutomers: a rational option for the treatment of asthma? Am J Respir Med 2002; 1: 305-11
21. Asmus MJ, Hendeles L, Weinberger M, et al. Levalbuterol has not been established to have therapeutic advantage over racemic albuterol [letter]. J Allergy Clin Immunol 2002; 110: 325
22. Milgrom H, Skoner DP, Bensch G, et al. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol 2001; 108: 938-45
23. Henry DA, Lexchin J. Medicines, health and commerce: a global perspective of the pharmaceutical industry: industry as a medicines provider. Lancet 2002; 360: 1590-5